SCHEMBL21363748

SCHEMBL21363748

C=CCc1cc2c(cc1COc1ccccc1C)OCO2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.46
MAPT P10636 7/20 0.43
ALDH1A1 P00352 4/20 0.43
SMN1; SMN2 Q16637 4/20 0.43
TSHR P16473 3/20 0.43
HTT P42858 1/20 0.43
KMT2A Q03164 4/20 0.42
TDP1 Q9NUW8 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
CYP3A4 P08684 3/20 0.42
CYP1A2 P05177 1/20 0.42
CDK4 P11802 1/20 0.42
CCND1 P24385 1/20 0.42
MEN1 O00255 2/20 0.40
TP53 P04637 2/20 0.40
KDM4E B2RXH2 2/20 0.40
HPGD P15428 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
HSD17B10 Q99714 1/20 0.40
GLA P06280 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21363678 0.87 CDK4 (0.45) NPC1MAPTALDH1A1SMN1; SMN2TSHR
SCHEMBL21363605 0.80 POLB (0.48) MAPTALDH1A1SMN1; SMN2TSHRKMT2A
SCHEMBL14552348 0.76 MAOB (0.54) NPC1MAPTALDH1A1SMN1; SMN2TSHR
SCHEMBL21363746 0.75 USP2 (0.44) NPC1MAPTALDH1A1SMN1; SMN2TSHR
SCHEMBL21363612 0.75 HPGD (0.44) NPC1MAPTALDH1A1SMN1; SMN2TSHR
SCHEMBL21363610 0.73 KMT2A (0.41) NPC1MAPTSMN1; SMN2TSHRHTT
SCHEMBL11696893 0.73 CYP3A4 (0.53) MAPTALDH1A1SMN1; SMN2KMT2ACYP3A4
SCHEMBL21363606 0.73 SLC6A4 (0.41) MAPTSMN1; SMN2TSHRKMT2ATDP1
SCHEMBL3521430 0.71 CDK4 (0.60) NPC1MAPTALDH1A1SMN1; SMN2TSHR
SCHEMBL21363758 0.70 CYP3A4 (0.63) NPC1MAPTALDH1A1SMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019175713-A1 NEW CATECHOL MOLECULES AND THEIR USE AS INHIBITORS TO P450 RELATED METABOLIC PATHWAYS BASF CORPORATION (US) 2019-09-19 WO disclosed
WO-2019175712-A1 NEW USES FOR CATECHOL MOLECULES AS INHIBITORS TO GLUTATHIONE S-TRANSFERASE METABOLIC PATHWAYS BASF CORPORATION (US) 2019-09-19 WO disclosed